Up at 5AM: The 5AM Solutions Blog

What We Talk About When We Talk About Curing Cancer

Posted on Tue, Mar 31, 2015 @ 05:01 PM

Last night, the three-night documentary series "Cancer: The Emperor of All Maladies" based on Siddartha Mukherjee's bestselling book premiered on PBS. In the first episode, the filmmakers traced the disease's history from a reference in a 15-foot, 4,000-year-old Egyptian medical parchment (under cures it reads: "There is none.") to the present, at the Kimmel Cancer Center at Johns Hopkins University, where two families are facing unimaginably difficult decisions about how to treat their children's leukemia.

Read More

Tags: cancer, cancer research, research

Ebola: New Outbreaks Amid New Hope for Vaccines

Posted on Fri, Mar 27, 2015 @ 03:00 PM

Liberia was poised to be the first of the three hardest-hit countries stricken with the Ebola epidemic to declare itself free from the deadly virus that has ravaged the region for a year. The West African nation had gone two weeks without a new infection; and then a 44-year-old street vendor developed a fever. Her teenaged daughter, who'd tended to her sick mother developed a telltale headache.

Read More

Tags: clinical trials, vaccines, ebola

Better EMRs Can Make Big Data More Relevant

Posted on Tue, Mar 24, 2015 @ 03:00 PM

Is healthcare technology good enough? Robert M. Wachter, M.D., Professor and Associate Chair of the Department of Medicine at UCSF says no. Or at least not most of it yet. He claims that most of the electronic medical records systems used in hospitals are so bad, that some physicians seeking new positions think that not having an EMR system is a perk.

Read More

Tags: health IT, EMR, Big Data

Drug Development and Discovery Going Viral

Posted on Thu, Mar 19, 2015 @ 03:00 PM

Last week, a Reddit user posted a link to an interesting project via the social media site’s You Should Know sidebar. It began, “YSK you can send a scoop of dirt from your backyard to a research group that will analyze it for new antibiotic elements and other medicines.

Read More

Tags: cancer, drug development

5 Reasons Apple's ResearchKit Moves Us Forward

Posted on Tue, Mar 17, 2015 @ 03:00 PM

Last week, Apple announced that it had released the first generation of ResearchKit. For those of us working to bring the internet to healthcare, the Web blew up with strong opinions about it. Whether you are for or against the new platform, it has to be acknowledged that it is an important step toward further uncloaking the world of biomedicine and making it accessible to lay consumers in the healthcare marketplace.

Read More

Tags: clinical trials, Research Kit, ResearchKit, Apple

Newly Approved Lung Cancer Drug Inhibits Immune Checkpoint

Posted on Fri, Mar 13, 2015 @ 03:00 PM

A couple of weeks ago, we blogged about the strides being made to combat melanomas by releasing the brakes on the immune system. Last week, the FDA approved Bristol-Myers Squibb's Opdivo (nivolumab), an immunotherapy drug that has had dramatic results in lengthening the lives of patients with some late-stage melanomas.

Read More

Tags: cancer, clinical trials, immunotherapy, drugs

5AM Solutions CSO Will FitzHugh Wins Executive Management Award

Posted on Tue, Mar 10, 2015 @ 03:00 PM

Last night, 5AM Solutions' Chief Science Officer Will FitzHugh was among the honorees at SmartCEO magazine's Washington Executive Management Awards. If you haven't worked with him directly, you might know Will from this blog. Most recently, he was the author of the Map of Biomedicine series (stay tuned for an upcoming ebook...) and he has also written about newborn screening and big data.

Read More

Tags: Big Data, map of biomedicine, 5AM, newborn screening

Slowing Down Aging from the Tips of Your Chromosomes

Posted on Thu, Mar 05, 2015 @ 03:00 PM

Misao Osaka -- the world's oldest person -- turned 117-years-old today. When asked how she achieved such an advanced age, Mrs. Osaka claims to be as baffled as most of us about the secret to longevity. "I wonder about that, too," she tells a reporter

Read More

Tags: cancer, aging, diabetes, chromosomes

The Comeback Kids: Old Drugs, New Uses

Posted on Tue, Mar 03, 2015 @ 03:00 PM

Drug development is a long, expensive process with a very high failure rate. In a 2011 commentary in the journal Science Translational Medicine, NIH director Francis Collins described it like this:

Read More

Tags: clinical trials, drug development, drugs


Diagnostic Tests on the Map of Biomedicine


Download the ebook based on our popular blog series. This free, 50+ page edition features updated, expanded posts and redesigned, easier-to-read maps. 

FREE Biobanking Ebook

Biobanking Free Ebook
Get this 29 page PDF document on how data science can be used to advance biorepositories.

 Free NGS Whitepaper

NGS White Paper for Molecular Diagnostics

Learn about the applications, opportunities and challenges in this updated free white paper. 

Recent Posts